Skip to main content
. 2020 Feb 20;37(1):42–47. doi: 10.4274/tjh.galenos.2019.2019.0241

Figure 1.

Figure 1

The harmonization of individual disease characteristics, the experience of physician/clinical facilities, and best clinical evidence is essential for clinical decision-making in chronic myeloid leukemia (CML).

CML: Chronic myeloid leukemia, TKI: Tyrosine kinase inhibitor.